HEADER TRANSFERASE 23-NOV-05 2F4J
TITLE STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL MUTANT IN
TITLE 2 COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 227-513;
COMPND 5 SYNONYM: P150, C- ABL;
COMPND 6 EC: 2.7.1.112;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: ABL1, ABL, JTK7;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-STAR;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A-TEV
KEYWDS KINASE, KINASE INHIBITOR, ABL, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR M.A.YOUNG,N.P.SHAH,L.H.CHAO,P.ZARRINKAR,P.SAWYERS,J.KURIYAN
REVDAT 5 23-AUG-23 2F4J 1 REMARK
REVDAT 4 20-OCT-21 2F4J 1 REMARK SEQADV
REVDAT 3 18-OCT-17 2F4J 1 REMARK
REVDAT 2 24-FEB-09 2F4J 1 VERSN
REVDAT 1 24-JAN-06 2F4J 0
JRNL AUTH M.A.YOUNG,N.P.SHAH,L.H.CHAO,M.SEELIGER,Z.V.MILANOV,
JRNL AUTH 2 W.H.BIGGS,D.K.TREIBER,H.K.PATEL,P.P.ZARRINKAR,D.J.LOCKHART,
JRNL AUTH 3 C.L.SAWYERS,J.KURIYAN
JRNL TITL STRUCTURE OF THE KINASE DOMAIN OF AN IMATINIB-RESISTANT ABL
JRNL TITL 2 MUTANT IN COMPLEX WITH THE AURORA KINASE INHIBITOR VX-680.
JRNL REF CANCER RES. V. 66 1007 2006
JRNL REFN ISSN 0008-5472
JRNL PMID 16424036
JRNL DOI 10.1158/0008-5472.CAN-05-2788
REMARK 2
REMARK 2 RESOLUTION. 1.91 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH & HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.29
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 85.5
REMARK 3 NUMBER OF REFLECTIONS : 23335
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.207
REMARK 3 FREE R VALUE : 0.239
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.900
REMARK 3 FREE R VALUE TEST SET COUNT : 1612
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.91
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.99
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 50.80
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1638
REMARK 3 BIN R VALUE (WORKING SET) : 0.2940
REMARK 3 BIN FREE R VALUE : 0.3650
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 87
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.039
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2328
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 33
REMARK 3 SOLVENT ATOMS : 211
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.80
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 12.14000
REMARK 3 B22 (A**2) : -8.84000
REMARK 3 B33 (A**2) : -3.30000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : -1.55000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.23
REMARK 3 ESD FROM SIGMAA (A) : 0.25
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.29
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.70
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.690
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : CNS BULK SOLVENT MODEL USED
REMARK 3 KSOL : 0.39
REMARK 3 BSOL : 47.71
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : VX680.PAR
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : CARBOHYDRATE.TOP
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: CROSS-VALIDATION METHOD:
REMARK 3 -> "THROUGHOUT"
REMARK 3 FREE R VALUE TEST SET SELECTION CRITERIA:
REMARK 3 -> "RANDOM"
REMARK 4
REMARK 4 2F4J COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-DEC-05.
REMARK 100 THE DEPOSITION ID IS D_1000035443.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 26-OCT-04
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 3.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : ALS
REMARK 200 BEAMLINE : 8.2.1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111)
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24731
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.12100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97
REMARK 200 COMPLETENESS FOR SHELL (%) : 56.1
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.52900
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: PHASER
REMARK 200 STARTING MODEL: PDB ENTRY 1M52
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 53.67
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 25% W/V PEG1500, 0.1M CITRIC ACID, PH
REMARK 280 3.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.70850
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 309 C - N - CA ANGL. DEV. = 10.6 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 245 -132.31 -116.25
REMARK 500 ASP A 276 -57.87 87.20
REMARK 500 THR A 277 144.69 -6.01
REMARK 500 PRO A 309 -108.39 10.53
REMARK 500 ASP A 363 42.78 -154.44
REMARK 500 ASP A 381 83.86 46.92
REMARK 500 PRO A 402 90.98 -67.39
REMARK 500 TYR A 440 63.27 38.98
REMARK 500 ASP A 455 16.22 84.24
REMARK 500 LEU A 510 -2.65 -59.60
REMARK 500 LYS A 512 -25.16 -168.29
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE VX6 A 514
DBREF 2F4J A 227 513 GB 62362414 NP_005148 227 513
SEQADV 2F4J PRO A 396 GB 62362414 HIS 396 ENGINEERED MUTATION
SEQADV 2F4J MET A 228 GB 62362414 VAL 228 CLONING ARTIFACT
SEQRES 1 A 287 GLY MET SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG
SEQRES 2 A 287 THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN
SEQRES 3 A 287 TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER
SEQRES 4 A 287 LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET
SEQRES 5 A 287 GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS
SEQRES 6 A 287 GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL
SEQRES 7 A 287 CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE
SEQRES 8 A 287 MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS
SEQRES 9 A 287 ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET
SEQRES 10 A 287 ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS
SEQRES 11 A 287 LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS
SEQRES 12 A 287 LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE
SEQRES 13 A 287 GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA
SEQRES 14 A 287 PRO ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO
SEQRES 15 A 287 GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP
SEQRES 16 A 287 VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR
SEQRES 17 A 287 TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN
SEQRES 18 A 287 VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG
SEQRES 19 A 287 PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG
SEQRES 20 A 287 ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE
SEQRES 21 A 287 ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU
SEQRES 22 A 287 SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS
SEQRES 23 A 287 GLN
HET VX6 A 514 33
HETNAM VX6 CYCLOPROPANECARBOXYLIC ACID {4-[4-(4-METHYL-PIPERAZIN-
HETNAM 2 VX6 1-YL)-6-(5-METHYL-2H-PYRAZOL-3-YLAMINO)-PYRIMIDIN-2-
HETNAM 3 VX6 YLSULFANYL]-PHENYL}-AMIDE
FORMUL 2 VX6 C23 H28 N8 O S
FORMUL 3 HOH *211(H2 O)
HELIX 1 1 GLU A 238 THR A 240 5 3
HELIX 2 2 GLY A 249 GLN A 252 5 4
HELIX 3 3 LYS A 263 SER A 265 5 3
HELIX 4 4 GLU A 279 LYS A 291 1 13
HELIX 5 5 ASN A 322 CYS A 330 1 9
HELIX 6 6 ASN A 336 ASN A 358 1 23
HELIX 7 7 ALA A 365 ARG A 367 5 3
HELIX 8 8 GLU A 373 HIS A 375 5 3
HELIX 9 9 PRO A 402 THR A 406 5 5
HELIX 10 10 ALA A 407 ASN A 414 1 8
HELIX 11 11 SER A 417 THR A 434 1 18
HELIX 12 12 ASP A 444 SER A 446 5 3
HELIX 13 13 GLN A 447 LYS A 454 1 8
HELIX 14 14 PRO A 465 TRP A 476 1 12
HELIX 15 15 ASN A 479 ARG A 483 5 5
HELIX 16 16 SER A 485 LEU A 510 1 26
SHEET 1 A 5 ILE A 242 LYS A 247 0
SHEET 2 A 5 VAL A 256 TRP A 261 -1 O VAL A 260 N THR A 243
SHEET 3 A 5 LEU A 266 THR A 272 -1 O VAL A 270 N TYR A 257
SHEET 4 A 5 TYR A 312 GLU A 316 -1 O ILE A 313 N LYS A 271
SHEET 5 A 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314
SHEET 1 B 2 PHE A 359 ILE A 360 0
SHEET 2 B 2 ARG A 386 LEU A 387 -1 O ARG A 386 N ILE A 360
SHEET 1 C 2 CYS A 369 VAL A 371 0
SHEET 2 C 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370
SHEET 1 D 2 TYR A 393 THR A 394 0
SHEET 2 D 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393
SITE 1 AC1 16 HOH A 9 HOH A 16 GLY A 249 TYR A 253
SITE 2 AC1 16 VAL A 256 ALA A 269 LYS A 271 GLU A 286
SITE 3 AC1 16 THR A 315 GLU A 316 PHE A 317 MET A 318
SITE 4 AC1 16 THR A 319 GLY A 321 LEU A 370 ASP A 381
CRYST1 44.768 59.417 66.896 90.00 98.42 90.00 P 1 21 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.022337 0.000000 0.003306 0.00000
SCALE2 0.000000 0.016830 0.000000 0.00000
SCALE3 0.000000 0.000000 0.015111 0.00000